Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 26 results for "Novartis Company"

Novartis India: Outcome of AGM
Money Control

Novartis India: Outcome of AGM

Please find enclosed a summary of the proceedings of the 69th Annual General Meeting of the Company held on July 28, 2017 in Mumbai. Money Control, 1 month ago

34 images for Novartis Company

MSN India, 2 weeks ago
Lets Recycle, 7 months ago, 7 months ago
Business Insider, 7 months ago
Reuters UK, 7 months ago
Sify, 7 months ago
Yahoo! Finance UK and Ireland, 7 months ago
Yahoo! UK and Ireland, 7 months ago
4 Traders, 7 months ago
Yahoo! News, 7 months ago

Drug giants hunt for Indian patients

Global pharmaceutical companies, from Indianapolis-based Eli Lilly & Co. to Switzerland’s Novartis AG, are heading into smaller cities and rural areas.
 MSN India1 month ago
Money Control

Novartis India Q1 net profit down 63 percent at Rs 7 crore

The company had posted a net profit of Rs 19.07 crore for the corresponding period of the previous fiscal, Novartis India said in a BSE filing.
 Money Control1 month ago

Oxford BioMedica wins big contract for Novartis cell therapy

Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019. The deal, announced by Oxford BioMedica ...
 Reuters2 months ago

What exactly is wrong with India's pharma companies?

Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation. The number of class action lawsuits filed against Indian pharmaceutical companies has gone up in recent times with US law firms alleging non-disclosure of investor-sensitive information and pay-for-delay conspiracies among other violations by these companies. Six drug companies or subsidiaries of the parent generic drug firms from India have been named in over a dozen class action lawsuits for alleged ...
 Rediff.com1 week ago
MSN India

Novartis puts Indian doctor from Harvard in charge as CEO

AG on Monday announced the surprise departure of Chief Executive Officer Joseph Jimenez after eight years at the helm of Europe's largest drugmaker, and the appointment of its drug development chief Vasanth Narasimhan as his successor. With this, Jiminez will ...
 MSN India2 weeks ago Novartis names drugs chief as CEO to deliver return to growth  Business Standard2 weeks ago Novartis names Indian-origin Vas Narasimhan as Global CEO  Money Control2 weeks ago Novartis names Indian-origin Vasant Narasimhan as new CEO  The Financial Chronicle2 weeks ago

Price fixation of essential drugs hits profitability: Novartis

The fixation of ceiling prices of essential drugs by the pharma pricing regulator NPPA has impacted the profitability of the company, drug firm Novartis India has said.
 DNA2 months ago

UPDATE 1-European shares open higher after record highs in Asia, Wall Street

* Stoxx 600 rises 0.3 pct * Financial stocks among top gainers * Insurance sector still up after Monday rally(Adds comments, more sectors) By Julien Ponthus LONDON, Sept 12 (Reuters) - European bourses continued theirrelief rally, opening higher on Tuesday ...
 Sify1 week ago

Why GSK is changing its strategy after 93 years

Increased price control over branded generic medicines has affected its profitability GlaxoSmithKline (GSK) Pharmaceuticals is scouting for acquisitions in the domestic market for the first time since it started its operations in the country 93 years ago. The change in strategy comes at a time when the government’ increasing price control over branded generic medicines has affected its profitability.   In the last five years, the revenue of the UK-headquartered company recorded a ...
 Rediff.com2 weeks ago

Infosys Raises Revenue Growth Forecast; Axis Bank in search of a new CEO and Stocks to Watch Out Today

Posted by Equitymaster Indian share markets ended the week marginally lower due to selling pressure in software stocks after muted results from TCS, the flagship software company. At the closing bell, the BSE Sensex stood lower by 17 points, while the NSE ...
 Equitymaster.com2 months ago Sensex Ends Marginally Lower; Software Stocks Fall on Muted Results  Equitymaster.com2 months ago Sensex Opens Marginally Down; TCS Results Disappoint  Equitymaster.com2 months ago Sensex Finishes Firm; Bank Stocks Rally  Equitymaster.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less